Share this post on:

Erythromycin

Erythromycin is a macrolide antibiotic that binds the 50s subunit of bacterial ribosomes, inhibiting protein synthesis by preventing transfer of tRNA from the A site to the P site. This compound displays antibacterial activity against both gram positive and gram negative bacteria; it also inhibits mammalian mRNA splicing.

References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/18922125

Cas No.

114-07-8

Purity

≥94%

Formula

C37H67NO13

Formula Wt.

733.93

Chemical Name

Erythromycin A

IUPAC Name

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

Synonym

Abomacetin; Aknin; EMU; E-Mycin; Erymax; Erycen; Erycin.

Melting Point

135-140°C

Solubility

Very slightly soluble in water (~2 mg/ml). Freely soluble in alcohols, acetone, ethyl acetate, acetonitrile or chloroform.

Appearance

White Crystal Powder

Hertweck M, Hiller R, Mueller MW. Inhibition of nuclear pre-mRNA splicing by antibiotics in vitro. Eur J Biochem. 2002 Jan;269(1):175-83. PMID: 11784311.

Menninger JR, Otto DP. Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes. Antimicrob Agents Chemother. 1982 May;21(5):811-8. PMID: 6179465.

SCH-900776